President Donald Trump is continuing his administration's push to lower prescription drug costs, announcing that nine additional biotech companies have joined his Most-Favored-Nation initiative. The administration says the effort is aimed at making medications more affordable for Americans, including treatments for chronic and rare diseases. CMS Administrator Dr. Mehmet Oz also highlighted efforts to expand access to lower-cost GLP-1 medications, while biotech executives discussed bringing more pharmaceutical manufacturing and clinical research back to the United States. Trump says his administration will continue working to reduce drug costs and wants Congress to codify the effort through the White House's proposed health care plan. Join this channel to get access to OAN Live & perks: https://www.youtube.com/channel/UCNbIDJNNgaRrXOD7VllIMRQ/join Visit us On OAN Live : https://live.oann.com/home.ktv Website: https://www.oann.com Facebook: https://www.facebook.com/OneAmericaNewsNetwork Twitter: https://twitter.com/OANN Instagram: https://www.instagram.com/one_america_news_ KlowdTV: Watch OAN Live on KlowdTV subscription prices start at $2.99 /mo https://klowdtv.com